Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 vaccine strategies must focus on severe disease and global equity
Peter McIntyre, Rakesh Aggarwal, Ilesh Jani, et al.
The Lancet (2021) Vol. 399, Iss. 10322, pp. 406-410
Open Access | Times Cited: 78

Showing 1-25 of 78 citing articles:

SARS-CoV-2 reinfections: Overview of efficacy and duration of natural and hybrid immunity
Stefan Pilz, Verena Theiler‐Schwetz, Christian Trummer, et al.
Environmental Research (2022) Vol. 209, pp. 112911-112911
Open Access | Times Cited: 232
The unintended consequences of COVID-19 vaccine policy: why mandates, passports and restrictions may cause more harm than good
Kevin Bardosh, Alexandre de Figueiredo, Rachel Gur‐Arie, et al.
BMJ Global Health (2022) Vol. 7, Iss. 5, pp. e008684-e008684
Open Access | Times Cited: 221
Emerging evidence on Omicron (B.1.1.529) SARS‐CoV‐2 variant
Vineet Sharma, Himanshu Rai, Dev Nath Singh Gautam, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 5, pp. 1876-1885
Open Access | Times Cited: 77
Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions
Duvuru Geetha, Andreas Kronbichler, Megan Rutter, et al.
Nature Reviews Nephrology (2022) Vol. 18, Iss. 11, pp. 724-737
Open Access | Times Cited: 69
Primary assessment of the diversity of Omicron sublineages and the epidemiologic features of autumn/winter 2022 COVID-19 wave in Chinese mainland
Gang Lü, Yun Ling, Minghao Jiang, et al.
Frontiers of Medicine (2023) Vol. 17, Iss. 4, pp. 758-767
Open Access | Times Cited: 40
Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern in real-world: a literature review and meta-analysis
Weihao Shao, Xiaorui Chen, Caifang Zheng, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 2383-2392
Open Access | Times Cited: 62
Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry
Jon Salmanton‐García, Francesco Marchesi, María Gomes da Silva, et al.
EClinicalMedicine (2023) Vol. 58, pp. 101939-101939
Open Access | Times Cited: 24
Lessons learnt from COVID-19 to reduce mortality and morbidity in the Global South: addressing global vaccine equity for future pandemics
Rebecca R. Martin, Allan Maleche, Jill Gay, et al.
BMJ Global Health (2024) Vol. 9, Iss. 1, pp. e013680-e013680
Open Access | Times Cited: 8
Decoupling of omicron variant infections and severe COVID-19
Shabir A. Madhi, Chikwe Ihekweazu, Helen Rees, et al.
The Lancet (2022) Vol. 399, Iss. 10329, pp. 1047-1048
Open Access | Times Cited: 27
Clinical Severity of SARS-CoV-2 Variants during COVID-19 Vaccination: A Systematic Review and Meta-Analysis
Zhilu Yuan, Zengyang Shao, Lijia Ma, et al.
Viruses (2023) Vol. 15, Iss. 10, pp. 1994-1994
Open Access | Times Cited: 20
Nanoplatform Based Intranasal Vaccines: Current Progress and Clinical Challenges
Ziyi Bai, Dandan Wan, Tianxia Lan, et al.
ACS Nano (2024) Vol. 18, Iss. 36, pp. 24650-24681
Open Access | Times Cited: 6
Longitudinal analysis of antibody titers after primary and booster mRNA COVID-19 vaccination can identify individuals at risk for breakthrough infection
Hyeongki Park, Naotoshi Nakamura, Shô Miyamoto, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
SARS-CoV-2 and COVID-19: A Narrative Review
Andrew D. Blann, Rebekka Heitmar
British Journal of Biomedical Science (2022) Vol. 79
Open Access | Times Cited: 26
Prevalence of long COVID decreases for increasing COVID-19 vaccine uptake
Manlio De Domenico
PLOS Global Public Health (2023) Vol. 3, Iss. 6, pp. e0001917-e0001917
Open Access | Times Cited: 12
Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial
Gustavo H. Dayan, Nadine Rouphael, Stephen R. Walsh, et al.
The Lancet Respiratory Medicine (2023) Vol. 11, Iss. 11, pp. 975-990
Open Access | Times Cited: 12
COVID-19 vaccine hesitancy among adults in India: A primary study based on health behavior theories and 5C psychological antecedents model
Sumit Aggarwal, Lucky Singh, Umaer Alam, et al.
PLoS ONE (2024) Vol. 19, Iss. 5, pp. e0294480-e0294480
Open Access | Times Cited: 4
The first 2 years of COVID-19 in Italy: Incidence, lethality, and health policies
Pierpaolo Ferrante
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 18
Comparative effectiveness of BNT162b2 and ChAdOx1 nCoV-19 vaccines against COVID-19
Jie Wei, Weiya Zhang, Michael Doherty, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 10
Dynamic variations in COVID-19 with the SARS-CoV-2 Omicron variant in Kazakhstan and Pakistan
Qianqian Cui, Zheng‐Li Shi, Duman Yimamaidi, et al.
Infectious Diseases of Poverty (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 10
Efficacy, Immunogenicity, and Safety of the Two-Dose Schedules of TURKOVAC versus CoronaVac in Healthy Subjects: A Randomized, Observer-Blinded, Non-Inferiority Phase III Trial
Mine Durusu Tanrıöver, Özlem Altuntaş Aydın, Rahmet Güner, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1865-1865
Open Access | Times Cited: 16
Assessing Vaccination Prioritization Strategies for COVID-19 in South Africa Based on Age-Specific Compartment Model
Chao Zuo, Zeyang Meng, Fenping Zhu, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 15
COVID-19 Vaccine Acceptance and Its Determinants in the General Population of Delhi, India: A State Level Cross-Sectional Survey
Pragya Sharma, Saurav Basu, Suruchi Mishra, et al.
Cureus (2022)
Open Access | Times Cited: 14
Predictors of SARS-CoV-2 Vaccine Uptake among Health Professionals: A Cross-Sectional Study in Ghana
Abdul-Samed Mohammed, Mubarick Nungbaso Asumah, Bijaya Kumar Padhi, et al.
Vaccines (2023) Vol. 11, Iss. 1, pp. 190-190
Open Access | Times Cited: 8
Vaccines reduced hospital length of stay and fraction of inspired oxygen of COVID-19 patients: A retrospective cohort study
Xiaomei Fang, Guofang Tao, Hua Zhou, et al.
Preventive Medicine Reports (2024) Vol. 39, pp. 102632-102632
Open Access | Times Cited: 2
Seroepidemiological assessment of SARS-CoV-2 vaccine responsiveness and associated factors in the vaccinated community of the Casablanca-Settat Region, Morocco
Sayeh Ezzikouri, Tajudeen Raji, Hind Majidi, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top